RESUMEN
BACKGROUND: The growing numbers of cancer survivors challenge delivery of high-quality survivorship care by healthcare systems. Innovative ways to improve care coordination for patients with cancer and multiple chronic conditions ("complex cancer survivors") are needed to achieve better care outcomes, improve patient experience of care, and lower cost. Our study, Project CONNECT, will adapt and implement three evidence-based care coordination strategies, shown to be effective for primary care conditions, among complex cancer survivors. Specifically, the purpose of this study is to: 1) Implement a system-level EHR-driven intervention for 500 complex cancer survivors at Parkland; 2) Test effectiveness of the strategies on system- and patient-level outcomes measured before and after implementation; and 3) Elucidate system and patient factors that facilitate or hinder implementation and result in differences in experiences of care coordination between complex patients with and without cancer. METHODS: Project CONNECT is a quasi-experimental implementation study among 500 breast and colorectal cancer survivors with at least one of the following chronic conditions: diabetes, hypertension, chronic lung disease, chronic kidney disease, or heart disease. We will implement three evidence-based care coordination strategies in a large, county integrated safety-net health system: 1) an EHR-driven registry to facilitate patient transitions between primary and oncology care; 2) co-locating a nurse practitioner trained in care coordination within a complex care team; 3) and enhancing teamwork through coaching. Segmented regression analysis will evaluate change in system-level (i.e. composite care quality score) and patient-level outcomes (i.e. self-reported care coordination). To evaluate implementation, we will merge quantitative findings with structured observations and physician and patient interviews. DISCUSSION: This study will result in an evaluation toolkit identifying key model elements, barriers, and facilitators that can be used to guide care coordination interventions in other safety-net settings. Because Parkland is a vanguard of safety-net healthcare nationally, findings will be widely applicable as other safety-nets move toward increased integration, enhanced EHR capability, and experience with growing patient diversity. Our proposal recognizes the complexity of interventions and scaffolds evidence-based strategies together to meet the needs of complex patients, systems of care, and service integration. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02943265 . Registered 24 October 2016.
Asunto(s)
Supervivientes de Cáncer , Continuidad de la Atención al Paciente , Prestación Integrada de Atención de Salud/métodos , Oncología Médica/métodos , Atención Primaria de Salud/métodos , Proveedores de Redes de Seguridad/métodos , Continuidad de la Atención al Paciente/normas , Prestación Integrada de Atención de Salud/normas , Prestación Integrada de Atención de Salud/tendencias , Femenino , Humanos , Masculino , Oncología Médica/normas , Oncología Médica/tendencias , Enfermeras Practicantes/normas , Enfermeras Practicantes/tendencias , Atención Primaria de Salud/normas , Atención Primaria de Salud/tendencias , Calidad de la Atención de Salud/normas , Calidad de la Atención de Salud/tendencias , Proveedores de Redes de Seguridad/normasAsunto(s)
Neoplasias de la Mama/diagnóstico por imagen , Competencia Clínica , Prestación Integrada de Atención de Salud/organización & administración , Comunicación Interdisciplinaria , Mamografía , Oncología Médica/organización & administración , Neoplasias/terapia , Grupo de Atención al Paciente/organización & administración , Femenino , HumanosRESUMEN
Patients and payers (government and private) are frustrated with the fee-for-service system (FFS) of payment for outpatient health services. FFS rewards volume and highly valued services, including expensive diagnostics and therapeutics, over lesser valued cognitive services. Proposed payment schemes would incent collaboration and coordination of care among providers and reward quality. In oncology, new payment schemes must address the high costs of all services, particularly drugs, while preserving the robust distribution of sites of service available to patients in the United States. Information technology and personalized cancer care are changing the practice of oncology. Twenty-first century oncology will require increasing cognitive work and shared decision making, both of which are not well regarded in the FFS model. A high proportion of health care dollars are consumed in the final months of life. Effective delivery of palliative and end-of-life care must be addressed by practice and by new models of payment. Value-based reimbursement schemes will require oncology practices to change how they are structured. Lessons drawn from the principles of primary care's Patient Centered Medical Home (PCMH) will help oncology practice to prepare for new schemes. PCMH principles place a premium on proactively addressing toxicities of therapies, coordinating care with other providers, and engaging patients in shared decision making, supporting the ideal of value defined in the triple aim-to measurably improve patient experience and quality of care at less cost. Payment reform will be disruptive to all. Oncology must be engaged in policy discussions and guide rational shifts in priorities defined by new payment models.
Asunto(s)
Atención Ambulatoria/economía , Servicios de Salud Comunitaria/economía , Prestación Integrada de Atención de Salud/economía , Planes de Aranceles por Servicios/economía , Costos de la Atención en Salud , Reforma de la Atención de Salud/economía , Oncología Médica/economía , Atención Ambulatoria/legislación & jurisprudencia , Atención Ambulatoria/organización & administración , Servicios de Salud Comunitaria/legislación & jurisprudencia , Servicios de Salud Comunitaria/organización & administración , Prestación Integrada de Atención de Salud/legislación & jurisprudencia , Prestación Integrada de Atención de Salud/organización & administración , Costos de los Medicamentos , Planes de Aranceles por Servicios/legislación & jurisprudencia , Planes de Aranceles por Servicios/organización & administración , Costos de la Atención en Salud/legislación & jurisprudencia , Reforma de la Atención de Salud/legislación & jurisprudencia , Reforma de la Atención de Salud/organización & administración , Gastos en Salud , Humanos , Oncología Médica/legislación & jurisprudencia , Oncología Médica/organización & administración , Modelos Organizacionales , Cuidados Paliativos/economía , Administración de la Práctica Médica/economía , Estados Unidos , Compra Basada en Calidad/economíaRESUMEN
This paper and the three presentations it supports are drawn from the theme of the 2012 Cancer Center Business Summit (CCBS): "Transitioning to Value-Based Oncology: Strategies to Survive and Thrive." The CCBS is a forum on oncology business innovation, and the principal question the organizers address each year is "What are the creative, innovative, and best business models and practices that are being conceived or piloted today that may provide a responsible and sustainable platform for the delivery of cancer care tomorrow?" At this moment in health care-when so much is in flux and new business models and solutions abound-the oncology sector has a solemn responsibility: to forge the business models and relationships that will help to define a new cancer care value proposition and a sustainable health care system of tomorrow for the benefit of the patients it serves to get it "right."